How should I use this medicine?

The recommended starting dose of MOUNJARO is 2.5 mg weekly, with gradual increases based on individual glycemic control needs.

Dosage and Administration

MOUNJARO is administered as a subcutaneous injection once a week. The recommended initial dose is 2.5 mg. After 4 weeks, if additional glycemic control is needed, the dose can be increased to 5 mg weekly. Further dose escalations in 2.5 mg increments can occur every 4 weeks, with a maximum dose of 15 mg per week. The injection can be administered at any time of day, with or without food, and the injection site should be rotated to minimize local reactions. It can be injected in the abdomen, thigh, or upper arm.

Mounjaro(Tirzepatide)
Adults with type 2 diabetes mellitus, specifically for improving glycemic control as an adjunct to diet and exercise.
RELATED ARTICLES
/ 0
0 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved